Related by context. Frequent words. (Click for all words.) 80 Drug Candidate 77 Clinical Trial Results 77 Receives Patent 76 Exclusive License 76 Completes Enrollment 75 FDA Clearance 75 Small Molecule 75 FDA Clears 74 RNAi Therapeutics 73 Phase III Clinical Trial 73 Receives FDA Clearance 72 Monoclonal Antibody 72 Study Demonstrates 72 Announces Issuance 72 Phase III Trial 71 Announces Initiation 71 Pivotal Phase III 70 Shows Promise 70 Significantly Reduces 70 Low Dose 70 Positive Opinion 69 Commercialize 69 Induces 69 FDA Approves 69 Awarded Patent 69 Initiates Phase 68 FDA Approval 68 Pivotal Phase 68 Receives Notice 68 Scientists Identify 68 Announces Publication 68 Reduces Risk 68 Researchers Identify 68 Combination Therapy 68 Researchers Develop 68 Orphan Drug Status 68 Inhibits 67 Patent Dispute 67 Pivotal Trial 67 Study Indicates 67 Monotherapy 67 Metastatic Melanoma 67 Chronic Hepatitis C 67 Patients Treated 66 Files Patent 66 Announces Presentation 66 Autoimmune Diseases 66 Cancer Cells 66 Announces Successful Completion 65 Fast Track Designation 65 Elderly Patients 65 k Clearance 65 Announces Positive 65 Postmenopausal Women 65 Advanced Prostate Cancer 65 Non Invasive 65 Cholesterol Drug 65 Reports Positive 65 Benign Prostatic Hyperplasia 65 Orphan Drug designation 65 Prostate Cancer Treatment 65 Clinical Study 65 Receives Positive 65 Receives Approval 64 Study Identifies 64 Cancer Vaccine 64 Cervical Cancer Vaccine 64 Study Confirms 64 Hepatitis C Virus 64 Drug Eluting Stent 64 Meta Analysis 64 Increases Risk 64 Bird Flu Vaccine 64 Announce Collaboration 64 Monoclonal Antibodies 63 Immunogenicity 63 Embryonic Stem Cells 63 Successful Completion 63 Hepatitis C Virus HCV 63 Licensing Deal 63 Patent Application 63 Extended Release 63 Brain Cells 63 Regulatory Approval 63 Diet Pill 63 Receives CE 62 Clinical Trial 62 Marketing Authorization 62 Discontinues 62 Orphan Drug status 62 Bevacizumab 62 Increased Risk 62 Markets Examine 62 Hormone Therapy 62 Microspheres 62 Enters Into Agreement 62 Enters Agreement 62 Issues Guidance 62 FDA Warns 62 Licensing Agreements 62 Successfully Completes